Developer docs
API playgroundTry for free, no card

Search company profiles

BIOTEC

Full company profile

uuid0038me7

Namestring
BIOTEC
Legal namestring
National Center for Genetic Engineering and Biotechnology
Websiteurl
biotec.or.th
Company typeenum
Private
Founded yearint
1983
Descriptiontext

BIOTEC (National Center for Genetic Engineering and Biotechnology) is a Thai government research institute established on 20 September 1983 and operated since 30 December 1991 as a center under the National Science and Technology Development Agency (NSTDA), functioning semi-autonomously outside the civil service framework. Headquartered at Thailand Science Park in Pathum Thani with approximately 570 staff (170 PhD researchers, 200 research assistants/technicians), BIOTEC conducts platform-technology R&D spanning agricultural biotechnology, biomedical science, and environmental science, with operating units also hosted at Thai universities.

The institute's technology portfolio comprises nucleic-acid diagnostic kits for shrimp pathogens (Ezee Gene: Nested PCR, Real-time PCR, LAMP Color), human diagnostics (i+LAB αTHAL thalassemia strip test, TB-DNAsensor Kit, LAMP-LFD malaria test, NS1 dengue ELISA), crop varieties (RD51 flood-tolerant jasmine rice, RD6 glutinous rice, AKG Tenera oil palm), feed enzymes (ENZboost, A-Zyme/Pentozyme), industrial enzymes (ENZease, ENZbleach), and the Plant Factory smart greenhouse system for controlled cultivation of medicinal herbs. Supporting infrastructure includes three subsidiaries — Thailand Bioresource Research Center (TBRC), National Omics Center (NOC), and National Biobank of Thailand (NBT) — plus BSL-2 laboratory and bioprocessing facilities.

BIOTEC's revenue model combines direct Thai government funding through NSTDA with commercial income from technology licensing to private companies (BioNet-Asia, i+MED Laboratories, Mobilis Automata, KEEEN, Asia Star Animal Health, Vicchi Enterprise, Peace Canning, PARWEL International, Drew-Bio, Eco Scientific, Sigma Aldrich), joint R&D contracts, fee-for-service technical work, and grants from international agencies (Medicines for Malaria Ventures, CSIRO, ARDA). Customers span aquaculture, agriculture, food, healthcare, and environmental sectors. Technology transfer is executed via licensing arrangements and partnerships through the NSTDA Technology Licensing Office; pricing for products and services is not publicly disclosed. GTM motions include direct industry consultation, joint research, technology licensing, and event-driven engagement through seminars and workshops such as InnoAgroindustry.

Short descriptiontext

BIOTEC is Thailand's national biotechnology research institute under NSTDA, conducting platform-technology R&D in agriculture, biomedicine, and the environment and licensing proprietary diagnostics, crop varieties, enzymes, and controlled-environment systems to private-sector partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBangkok, Thailand
HQ citystring
Bangkok
HQ countrystring
Thailand
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
biotechnology research services, genetic engineering, molecular diagnostics, agricultural biotechnology, environmental biotechnology
Industry4 codes
1Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development)
CodeHLAAAIADPrimaryYes
2Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling)
CodeHLAAAJAFPrimaryNo
3Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES)
CodeHLAAAJAEPrimaryNo
4Microbiology & Infectious Disease Testing (Trial Support)
CodeHLAGAEAFPrimaryNo
NAICS code4 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Biological Product (except Diagnostic) Manufacturing325414
  • Medicinal and Botanical Manufacturing325411
  • Pesticide and Other Agricultural Chemical Manufacturing32532
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Biotechnology Research Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Government Funding
TypeSubscription Recurring
Description

Core funding from Thai government through NSTDA to support basic research, national biotechnology programs, and public-interest research initiatives.

biotec.or.th
2Commercialization and Services Revenue
TypeLicensing Royalties
Description

Income from providing technical services, technology licensing, and commercializing research outputs to private sector and international funding agencies.

biotec.or.th
3Private Foundation and International Agency Funding
TypeManaged Services
Description

Revenue from non-government entities, international funding agencies, and private foundations for collaborative research projects.

biotec.or.th
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

BIOTEC is Thailand's national biotechnology research institute operating under NSTDA, conducting applied R&D across agricultural science, biomedical science, and environmental science. It develops and commercializes proprietary diagnostic kits (LAMP/PCR-based for shrimp viruses, thalassemia, malaria, tuberculosis, dengue), crop varieties (rice, oil palm), industrial enzymes, biopesticides, fermented feed additives, wastewater treatment systems, and a smart Plant Factory platform, primarily through technology licensing to private companies, technical consulting, and direct sales via specialized laboratories.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 80% organic matter removal achieved by wastewater treatment systems
+3 more records
Product overview1 text field

BIOTEC is Thailand's national research institute under NSTDA operating in biotechnology R&D. The organization offers a portfolio of diagnostic products (shrimp disease PCR/LAMP kits, human health tests for thalassemia/tuberculosis/malaria/dengue), agricultural biotechnology products (rice varieties, oil palm lines, biopesticides, feed enzymes, starter cultures), environmental technologies (biogas wastewater systems, bioremediation agents, denitrification reactors), and service platforms (FoodSERP for food innovation, Plant Factory for controlled-environment cultivation). Products are commercialized through licensing to private companies, technology transfer, and direct sales via specialized business units. The portfolio spans animal health, crop science, food technology, environmental management, and biomedical diagnostics.

Product and service1 record
1Shrimp Disease Diagnostic Tests
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership23 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on1991-12-30
Description

BIOTEC became one of NSTDA centers in 1991, operating outside normal civil service framework. NSTDA coordinates research funding activities and program management. Other NSTDA centers include MTEC, NECTEC, NANOTEC, and TMC.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Collaboration on onsite microbial reactor for biological wastewater treatment. KEEEN manufactures the OMR reactor commercially. Also collaborated on bioremediation product development (KEEEN brand).

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed Real-AMP LAMP-Turbidimeter technology for shrimp virus detection. Equipment marketed under Real-AMP brand, reagent as AMP Plus.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partner in Biologics and Pharmaceuticals Manufacturing in Thailand for Equitable Access to Medicines (BPM-TEAM) project with CSIRO and KMUTT.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Australia's national science agency. Partner in BPM-TEAM project to strengthen Thailand's pharmaceutical and biologics manufacturing capabilities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Japanese company focused on food innovation through genome editing. Discussed potential collaborations on allergy-reduced eggs and food technology.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Not-for-profit organization that selected P218 antimalarial drug candidate for further development. Supporting pre-clinical studies.

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed immunochromatographic thalassemia detection technology. Product commercialized as i+LAB αTHAL.

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed four serotypes of chimeric live-attenuated dengue vaccine candidate in February 2011 for commercial development.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Economic delegation visiting to discuss potential research collaborations in food innovation and genome editing.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Hosted visit to strengthen Thailand-Australia research collaboration and explore national research infrastructure ecosystem.

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed IC strip test technology for detection of bacterial fruit blotch disease in cucurbits.

13Micro Innovate Co., Ltd.
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Joint investment over 100 million Baht between NSTDA, private company, and researchers for industrial-scale microbial production plant for animal feed. First of its kind in Thailand.

biotec.or.th
Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed starter culture technology for industrial production of pickled mustard greens including large-scale fermentation.

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Leading food ingredient company offering commercial starter cultures for fermented pork sausage (Nham) in liquid and powder forms.

16Asia Star Animal Health Co., Ltd.
Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed pentosanase enzyme technology. Products available as A-Zyme and Pentozyme feed additives.

biotec.or.th
17Eco Scientific Co., Ltd.
Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed portable dissolved oxygen test kit for commercialization.

biotec.or.th
18Drew-Bio (Thailand) Co., Ltd.
Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed thalassemia interpretation tool as added-on feature for Low Pressure Liquid Chromatography (LPLC) equipment.

biotec.or.th
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaborated on TB-DNAsensor Kit development for tuberculosis diagnosis.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Implemented hormone-based ovulation synchronization protocol for dairy cattle, along with dairy cooperatives and over 1,000 smallholder farmers.

21MK Farm (Chiang Mai)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Validating disease-free orange production method through shoot-tip culture at farm in Fang District.

biotec.or.th
22Pak Hai Farmers Cooperative
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Successfully created business from Homcholasit rice production, selling branded 'On-waan' rice in supermarket chains.

biotec.or.th
Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Licensed three microorganisms (Xylaria spp., Verticillium spp., Lentinus spp.) for commercial production of depudecin, ascochlorin, and panepoxydone.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Singapore's national R&D agency running biomedical, biotechnology, and platform technology programs with industry transfer. Highly comparable mandate to BIOTEC as a Southeast Asian government biotech research institute.

TypeBroad incumbent
Description

Germany's applied research network with a model of government-funded institutes conducting contract research and technology licensing to industry. Highly comparable applied-research-plus-tech-transfer model at much larger scale and broader scope.

TypeBroad incumbent
Description

Japan's national research institute covering life sciences, computational biology, and bioengineering. Comparable as a government-funded multidisciplinary biotech research organization, though RIKEN is more focused on fundamental discovery than applied transfer.

TypeDirect peer
Description

Australia's national science agency and BIOTEC's direct BPM-TEAM partner. CSIRO performs applied biotech R&D with technology transfer to industry and operates national research infrastructure — a near-mirror of BIOTEC's mandate at larger scale.

TypeRegional player
Description

South Korea's government bioscience and biotechnology research institute conducting applied R&D with industry partnerships. Highly comparable mandate and Asian government research model, though operating in a different national market.

TypeRegional player
Description

Indonesia's government agricultural biotechnology research arm operating under the Ministry of Agriculture. Comparable in agricultural biotech focus and Southeast Asian government research model, though narrower in life sciences scope than BIOTEC.

TypeOthers
Description

Thai vaccine manufacturer that licensed BIOTEC's dengue vaccine candidate in 2011. Comparable as a Thai biotech commercialization partner dependent on BIOTEC-derived technologies and serves as an example of BIOTEC's industry transfer pipeline.

TypeRegional player
Description

Thai biopharmaceutical contract manufacturer with strong government ties producing vaccines and biologics. Comparable as a Thai biotech industry counterpart that benefits from BIOTEC's upstream R&D and platform technology pipeline.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BIOTEC

Biotechnology Research Servicesbiotec.or.th

BIOTEC is Thailand's national biotechnology research institute under NSTDA, conducting platform-technology R&D in agriculture, biomedicine, and the environment and licensing proprietary diagnostics, crop varieties, enzymes, and controlled-environment systems to private-sector partners.

What BIOTEC does

BIOTEC (National Center for Genetic Engineering and Biotechnology) is a Thai government research institute established on 20 September 1983 and operated since 30 December 1991 as a center under the National Science and Technology Development Agency (NSTDA), functioning semi-autonomously outside the civil service framework. Headquartered at Thailand Science Park in Pathum Thani with approximately 570 staff (170 PhD researchers, 200 research assistants/technicians), BIOTEC conducts platform-technology R&D spanning agricultural biotechnology, biomedical science, and environmental science, with operating units also hosted at Thai universities.

The institute's technology portfolio comprises nucleic-acid diagnostic kits for shrimp pathogens (Ezee Gene: Nested PCR, Real-time PCR, LAMP Color), human diagnostics (i+LAB αTHAL thalassemia strip test, TB-DNAsensor Kit, LAMP-LFD malaria test, NS1 dengue ELISA), crop varieties (RD51 flood-tolerant jasmine rice, RD6 glutinous rice, AKG Tenera oil palm), feed enzymes (ENZboost, A-Zyme/Pentozyme), industrial enzymes (ENZease, ENZbleach), and the Plant Factory smart greenhouse system for controlled cultivation of medicinal herbs. Supporting infrastructure includes three subsidiaries — Thailand Bioresource Research Center (TBRC), National Omics Center (NOC), and National Biobank of Thailand (NBT) — plus BSL-2 laboratory and bioprocessing facilities.

BIOTEC's revenue model combines direct Thai government funding through NSTDA with commercial income from technology licensing to private companies (BioNet-Asia, i+MED Laboratories, Mobilis Automata, KEEEN, Asia Star Animal Health, Vicchi Enterprise, Peace Canning, PARWEL International, Drew-Bio, Eco Scientific, Sigma Aldrich), joint R&D contracts, fee-for-service technical work, and grants from international agencies (Medicines for Malaria Ventures, CSIRO, ARDA). Customers span aquaculture, agriculture, food, healthcare, and environmental sectors. Technology transfer is executed via licensing arrangements and partnerships through the NSTDA Technology Licensing Office; pricing for products and services is not publicly disclosed. GTM motions include direct industry consultation, joint research, technology licensing, and event-driven engagement through seminars and workshops such as InnoAgroindustry.

BIOTEC firmographics

Firmographics
Name
BIOTEC
Legal name
National Center for Genetic Engineering and Biotechnology
Website
https://biotec.or.th
Company type
Private
Founded year
1983
Operating status
Operating
Headcount range
501–1,000 employees
Short description
BIOTEC is Thailand's national biotechnology research institute under NSTDA, conducting platform-technology R&D in agriculture, biomedicine, and the environment and licensing proprietary diagnostics, crop varieties, enzymes, and controlled-environment systems to private-sector partners.
Ownership category
akta.pro rank

BIOTEC industry classification

Industry
Product category
Biotechnology Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414), Medicinal and Botanical Manufacturing (325411), Pesticide and Other Agricultural Chemical Manufacturing (32532)
SIC
Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
akta.pro secondary industries
Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE), Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

  • Biotechnology research services
  • Genetic engineering
  • Molecular diagnostics
  • Agricultural biotechnology
  • Environmental biotechnology

Where BIOTEC is headquartered

Location

Headquarters

HQ city
Bangkok
HQ country
Thailand
HQ region
Asia

Offices1 record

Markets served

BIOTEC business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Government Funding: Core funding from Thai government through NSTDA to support basic research, national biotechnology programs, and public-interest research initiatives.
  2. Commercialization and Services Revenue: Income from providing technical services, technology licensing, and commercializing research outputs to private sector and international funding agencies.
  3. Private Foundation and International Agency Funding: Revenue from non-government entities, international funding agencies, and private foundations for collaborative research projects.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

BIOTEC product offering

Product offering

Core offering

BIOTEC is Thailand's national biotechnology research institute operating under NSTDA, conducting applied R&D across agricultural science, biomedical science, and environmental science. It develops and commercializes proprietary diagnostic kits (LAMP/PCR-based for shrimp viruses, thalassemia, malaria, tuberculosis, dengue), crop varieties (rice, oil palm), industrial enzymes, biopesticides, fermented feed additives, wastewater treatment systems, and a smart Plant Factory platform, primarily through technology licensing to private companies, technical consulting, and direct sales via specialized laboratories.

Product overview

BIOTEC is Thailand's national research institute under NSTDA operating in biotechnology R&D. The organization offers a portfolio of diagnostic products (shrimp disease PCR/LAMP kits, human health tests for thalassemia/tuberculosis/malaria/dengue), agricultural biotechnology products (rice varieties, oil palm lines, biopesticides, feed enzymes, starter cultures), environmental technologies (biogas wastewater systems, bioremediation agents, denitrification reactors), and service platforms (FoodSERP for food innovation, Plant Factory for controlled-environment cultivation). Products are commercialized through licensing to private companies, technology transfer, and direct sales via specialized business units. The portfolio spans animal health, crop science, food technology, environmental management, and biomedical diagnostics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Shrimp Disease Diagnostic Tests

Quantifiable outcome

  • Over 80% organic matter removal achieved by wastewater treatment systems
  • +3 more outcomes

Companies that use BIOTEC

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles5 records

BIOTEC technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

BIOTEC partnerships and signals

Strategic signal

Partnerships

23 partnerships are on record, tiered core, major and minor.

  • National Science and Technology Development Agency (NSTDA)coreStrategic or Co-development Partner · 30 December 1991BIOTEC became one of NSTDA centers in 1991, operating outside normal civil service framework. NSTDA coordinates research funding activities and program management. Other NSTDA centers include MTEC, NECTEC, NANOTEC, and TMC.
  • KEEEN LimitedmajorStrategic or Co-development PartnerCollaboration on onsite microbial reactor for biological wastewater treatment. KEEEN manufactures the OMR reactor commercially. Also collaborated on bioremediation product development (KEEEN brand).
  • Mobilis Automata Co., Ltd.majorOEM/ Whitelabel/ Licensing PartnerLicensed Real-AMP LAMP-Turbidimeter technology for shrimp virus detection. Equipment marketed under Real-AMP brand, reagent as AMP Plus.
  • Government Pharmaceutical Organization (GPO)majorStrategic or Co-development PartnerPartner in Biologics and Pharmaceuticals Manufacturing in Thailand for Equitable Access to Medicines (BPM-TEAM) project with CSIRO and KMUTT.
  • Commonwealth Scientific and Industrial Research Organisation (CSIRO)majorStrategic or Co-development PartnerAustralia's national science agency. Partner in BPM-TEAM project to strengthen Thailand's pharmaceutical and biologics manufacturing capabilities.
  • Pt.Bio Inc.minorStrategic or Co-development PartnerJapanese company focused on food innovation through genome editing. Discussed potential collaborations on allergy-reduced eggs and food technology.
  • Medicines for Malaria VenturesmajorStrategic or Co-development PartnerNot-for-profit organization that selected P218 antimalarial drug candidate for further development. Supporting pre-clinical studies.
  • i+MED Laboratories Company LimitedmajorOEM/ Whitelabel/ Licensing PartnerLicensed immunochromatographic thalassemia detection technology. Product commercialized as i+LAB αTHAL.
  • BioNet-Asia Co., Ltd.majorOEM/ Whitelabel/ Licensing PartnerLicensed four serotypes of chimeric live-attenuated dengue vaccine candidate in February 2011 for commercial development.
  • Embassy of JapanminorGTM or Marketing PartnerEconomic delegation visiting to discuss potential research collaborations in food innovation and genome editing.
  • Australia's Chief ScientistminorGTM or Marketing PartnerHosted visit to strengthen Thailand-Australia research collaboration and explore national research infrastructure ecosystem.
  • PARWEL INTERNATIONAL CO., LTD.majorOEM/ Whitelabel/ Licensing PartnerLicensed IC strip test technology for detection of bacterial fruit blotch disease in cucurbits.
  • Micro Innovate Co., Ltd.majorStrategic or Co-development PartnerJoint investment over 100 million Baht between NSTDA, private company, and researchers for industrial-scale microbial production plant for animal feed. First of its kind in Thailand.
  • Peace Canning Co., Ltd.majorOEM/ Whitelabel/ Licensing PartnerLicensed starter culture technology for industrial production of pickled mustard greens including large-scale fermentation.
  • Vicchi Enterprise Co., Ltd.majorOEM/ Whitelabel/ Licensing PartnerLeading food ingredient company offering commercial starter cultures for fermented pork sausage (Nham) in liquid and powder forms.
  • Asia Star Animal Health Co., Ltd.majorOEM/ Whitelabel/ Licensing PartnerLicensed pentosanase enzyme technology. Products available as A-Zyme and Pentozyme feed additives.
  • Eco Scientific Co., Ltd.majorOEM/ Whitelabel/ Licensing PartnerLicensed portable dissolved oxygen test kit for commercialization.
  • Drew-Bio (Thailand) Co., Ltd.majorOEM/ Whitelabel/ Licensing PartnerLicensed thalassemia interpretation tool as added-on feature for Low Pressure Liquid Chromatography (LPLC) equipment.
  • Srinakharinwirot UniversityminorStrategic or Co-development PartnerCollaborated on TB-DNAsensor Kit development for tuberculosis diagnosis.
  • Charoen Pokphand Foods PCLmajorStrategic or Co-development PartnerImplemented hormone-based ovulation synchronization protocol for dairy cattle, along with dairy cooperatives and over 1,000 smallholder farmers.
  • MK Farm (Chiang Mai)minorStrategic or Co-development PartnerValidating disease-free orange production method through shoot-tip culture at farm in Fang District.
  • Pak Hai Farmers CooperativeminorStrategic or Co-development PartnerSuccessfully created business from Homcholasit rice production, selling branded 'On-waan' rice in supermarket chains.
  • Sigma AldrichmajorOEM/ Whitelabel/ Licensing PartnerLicensed three microorganisms (Xylaria spp., Verticillium spp., Lentinus spp.) for commercial production of depudecin, ascochlorin, and panepoxydone.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

BIOTEC competitors and assessment

Company assessment

Direct peers

Broad incumbents

  • Fraunhofer Society: Germany's applied research network with a model of government-funded institutes conducting contract research and technology licensing to industry. Highly comparable applied-research-plus-tech-transfer model at much larger scale and broader scope.
  • RIKEN: Japan's national research institute covering life sciences, computational biology, and bioengineering. Comparable as a government-funded multidisciplinary biotech research organization, though RIKEN is more focused on fundamental discovery than applied transfer.

Regional players

  • Korea Research Institute of Bioscience and Biotechnology (KRIBB): South Korea's government bioscience and biotechnology research institute conducting applied R&D with industry partnerships. Highly comparable mandate and Asian government research model, though operating in a different national market.
  • Indonesian Agency for Agricultural Research and Development (IAARD): Indonesia's government agricultural biotechnology research arm operating under the Ministry of Agriculture. Comparable in agricultural biotech focus and Southeast Asian government research model, though narrower in life sciences scope than BIOTEC.
  • Siam Bioscience Co., Ltd. Thai biopharmaceutical contract manufacturer with strong government ties producing vaccines and biologics. Comparable as a Thai biotech industry counterpart that benefits from BIOTEC's upstream R&D and platform technology pipeline.

Others

  • BioNet-Asia Co., Ltd. Thai vaccine manufacturer that licensed BIOTEC's dengue vaccine candidate in 2011. Comparable as a Thai biotech commercialization partner dependent on BIOTEC-derived technologies and serves as an example of BIOTEC's industry transfer pipeline.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

BIOTEC social profiles

Digital presence

BIOTEC financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BIOTEC leadership team

Management profile

Number of profiles

Profiles6 records

BIOTEC subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

BIOTEC funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BIOTEC M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOTEC

What does BIOTEC do?

BIOTEC is Thailand's national biotechnology research institute operating under NSTDA, conducting applied R&D across agricultural science, biomedical science, and environmental science. It develops and commercializes proprietary diagnostic kits (LAMP/PCR-based for shrimp viruses, thalassemia, malaria, tuberculosis, dengue), crop varieties (rice, oil palm), industrial enzymes, biopesticides, fermented feed additives, wastewater treatment systems, and a smart Plant Factory platform, primarily through technology licensing to private companies, technical consulting, and direct sales via specialized laboratories.

Is BIOTEC a public or private company?

BIOTEC is a private company. It is classified as state government owned and is currently operating.

When was BIOTEC founded?

BIOTEC was founded in 1983. It employs 501 to 1,000 people.

Where is BIOTEC based?

BIOTEC is headquartered in Bangkok, Thailand, in the Asia region.

How does BIOTEC make money?

Three revenue lines are on record. Government Funding is the primary driver. The others are commercialization and Services Revenue and private Foundation and International Agency Funding.

Who are BIOTEC's main competitors?

Direct peers on record are A*STAR (Agency for Science, Technology and Research) and CSIRO (Commonwealth Scientific and Industrial Research Organisation). Broad incumbents are Fraunhofer Society and RIKEN. Regional players are Korea Research Institute of Bioscience and Biotechnology (KRIBB), Indonesian Agency for Agricultural Research and Development (IAARD) and Siam Bioscience Co., Ltd.. BioNet-Asia Co., Ltd. is listed as an others.

Does BIOTEC have an API?

No public API is recorded for BIOTEC.

What industry is BIOTEC in?

BIOTEC's product category is Biotechnology Research Services. Its primary akta.pro industry code is HLAAAIAD, Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development), with a secondary code of HLAAAJAF, Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling). Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals